Coronavirus (COVID-19)

The Indian Health Service continues to work closely with our tribal partners and state and local public health officials to coordinate a comprehensive public health response to the ongoing COVID-19 pandemic. The federal government is working closely with state, local, tribal, and territorial partners, as well as public health partners, to respond to this public health threat.

The IHS formed a Critical Care Response Team [PDF] of expert physicians, registered nurses, and other healthcare professionals provide urgent lifesaving medical care on an as needed basis to COVID-19 patients admitted to IHS or tribal hospitals. The IHS has also rapidly deployed telehealth services Exit Disclaimer: You Are Leaving www.ihs.gov  both to maintain routine patient care and to allow critical care consultation for COVID-19 patients.

The IHS has received nearly $3 billion in funding to provide resources for IHS, tribal, and urban Indian health programs to prepare for and respond to the coronavirus pandemic. We have worked closely with tribes and urban Indian organizations throughout this pandemic to get resources out to facilities as quickly as possible. Additionally, the IHS has distributed rapid point-of-care testing systems and supplies Exit Disclaimer: You Are Leaving www.ihs.gov  and remdesivir [PDF], an investigational antiviral medicine to treat certain people in the hospital with COVID-19, at no cost to tribal and IHS facilities.

More information on the IHS response can be found in the IHS Covid-19 Response 100 Day Review [PDF – 411 KB] and Executive Summary [PDF – 207 KB]. This report covers actions taken by the IHS to support federal, tribal, and Urban Indian Organizations between March 6, 2020 through June 14, 2020.

For the latest general information about COVID-19, we encourage everyone to periodically review CDC’s COVID-19 webpage Exit Disclaimer: You Are Leaving www.ihs.gov  .

COVID-19 Vaccine Distribution and Administration by IHS Area

As of March 8, 2021, the IHS is distributing vaccine allocations of the Pfizer, Moderna, and Johnson & Johnson/Janssen vaccine. The table below shows the total number of vaccine doses distributed and administered per IHS Area to date.

Area	Total Doses Distributed*	Total Doses Administered**
Albuquerque	89,375	66,837
Bemidji	67,655	50,786
Billings	31,385	24,382
California	97,595	45,686
Great Plains	77,360	45,241
Nashville	43,995	28,513
Navajo	189,705	136,814
Oklahoma City	364,050	161,976
Phoenix	108,690	68,865
Portland	49,355	36,873
Tucson^	6,400	4,420
Grand Total	1,125,565	670,393

*Distributed Data Source: IHS National Supply Service Center, includes total doses ordered and anticipated to be delivered by March 5, 2021.

**Administered Data Source: CDC Clearinghouse data from Vaccine Administration Management System (VAMS) and IHS Central Aggregator Service (CAS). Data in the CDC Clearinghouse reflects prior day data. Data may be different than actual data as there are known CDC data lags and ongoing quality review of data including resolving data errors.

^The Tucson Area vaccine administration data is currently being validated.

Note: Alaska Area – all tribes chose to receive COVID-19 vaccine from the State of Alaska.

COVID-19 Cases by IHS Area

Data are reported from IHS, tribal, and urban Indian organization facilities, though reporting by tribal and urban programs is voluntary. Data reflect cases reported to the IHS through 11:59 pm on March 9, 2021.

IHS Area	Tested	Positive	Negative	Cumulative percent positive *	7-day rolling average positivity *
Alaska	533,315	11,254	451,938	2.4%	0.7%
Albuquerque	89,663	8,030	61,451	11.6%	4.8%
Bemidji	143,784	10,157	130,079	7.2%	3.3%
Billings	94,491	7,302	83,933	8.0%	2.0%
California	71,770	7,537	60,557	11.1%	10.9%
Great Plains	134,335	13,912	119,902	10.4%	5.7%
Nashville	70,411	5,935	63,509	8.5%	4.8%
Navajo	230,042	31,061	156,504	16.6%	5.0%
Oklahoma City	453,768	59,519	389,164	13.3%	4.9%
Phoenix	164,887	23,147	140,881	14.1%	3.7%
Portland	104,754	7,256	96,753	7.0%	2.5%
Tucson	24,751	2,717	21,881	11.0%	3.1%
TOTAL	2,115,971	187,827	1,776,552	9.6%	3.1%

* Cumulative percent positive and 7-day rolling average positivity are updated three days per week.